HT my thoughts on Mylan have always been a bit on the pessimistic side, in so much that if POH does not succeed with the claim at least where RM has now got us "positioned" with the others you list,they give us some sort of backbone which has been severely lacking and Terumo indeed give us a big, actually huge chance at what POH was and is all about, an Oxymorphone patch. Success with the Mylan claim to state the bleeding obvious, would certainly would put POH in a very bright spotlight in regards to the market. omo
Buy Recommendation The Australian, page-32
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(50.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.3¢ | 0.2¢ | $52 | 21.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 6846739 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 41919123 | 29 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |